![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/08/RP-206-400x400.png)
Equity and Pandemic Preparedness: Navigating the 2024 Amendments to the International Health Regulations
Research Paper 206, 28 August 2024
By Nirmalya Syam
Research Paper 206, 28 August 2024
By Nirmalya Syam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/07/RP-204-400x400.png)
Negotiating Health and Autonomy: Data Exclusivity, Healthcare Policies and Access to Pharmaceutical Innovations
Research Paper 204, 24 July 2024
By Henrique Zeferino De Menezes, Julia Paranhos, Ricardo Lobato Torres, Luciana Correia Borges, Daniela De Santana Falcão and Gustavo Soares Felix Lima
Research Paper 204, 24 July 2024
By Henrique Zeferino De Menezes, Julia Paranhos, Ricardo Lobato Torres, Luciana Correia Borges, Daniela De Santana Falcão and Gustavo Soares Felix Lima
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/07/RP-203-2-400x400.png)
The Vaccine Industry After the COVID-19 Pandemic: An International Perspective
Research Paper 203, 11 July 2024
By Felix Lobo
Research Paper 203, 11 July 2024
By Felix Lobo
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/06/RP-198-400x400.png)
What Can Cambodia Learn from Thailand and India as It Prepares to Graduate from Least Developed Country Status?
Research Paper 198, 31 May 2024
By Brigitte Tenni, Deborah Gleeson, Joel Lexchin, Phin Sovath, and Chalermsak Kittitrakul
Research Paper 198, 31 May 2024
By Brigitte Tenni, Deborah Gleeson, Joel Lexchin, Phin Sovath, and Chalermsak Kittitrakul
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/05/RP-197-400x400.png)
Compulsory Licensing as a Remedy Against Excessive Pricing of Life-Saving Medicines
Research Paper 197, 28 May 2024
By Behrang Kianzad
Research Paper 197, 28 May 2024
By Behrang Kianzad
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/04/RP-196-400x400.png)
Licencias obligatorias para exportación: operacionalización en el orden jurídico argentino
Documento de Investigación 196, 19 de abril de 2024
Por Valentina Delich
Documento de Investigación 196, 19 de abril de 2024
Por Valentina Delich
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/03/RP-195-400x400.png)
Régimen de licencias obligatorias y uso público no comercial en Argentina
Documento de Investigación 195, 6 de marzo de 2024
Por Juan Ignacio Correa
Documento de Investigación 195, 6 de marzo de 2024
Por Juan Ignacio Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/02/RP-194-400x400.png)
Implementation of TRIPS Flexibilities and Injunctions: A Case Study of India
Research Paper 194, 15 February 2024
By Shirin Syed
Research Paper 194, 15 February 2024
By Shirin Syed
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/04/RP19365-400x400.jpg)
Desafíos actuales y posibles escenarios futuros de la salud mundial
Documento de Investigación 193, 2 de Febrero de 2024
By Germán Velásquez
Documento de Investigación 193, 2 de Febrero de 2024
By Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/01/RP-192-400x400.png)
Pautas para el examen de patentes sobre anticuerpos monoclonales
Documento de Investigación 192, 30 de enero de 2024
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
Documento de Investigación 192, 30 de enero de 2024
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/01/RP-191-400x400.png)
TRIPS Waiver Decision for Equitable Access to Medical Countermeasures in the Pandemic: COVID-19 Diagnostics and Therapeutics
Research Paper 191, 25 January 2024
By Nirmalya Syam and Muhammad Zaheer Abbas, PhD
Research Paper 191, 25 January 2024
By Nirmalya Syam and Muhammad Zaheer Abbas, PhD
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/01/RP-190-400x400.png)
Implementing the Doha Declaration in OAPI Legislation: Do Transition Periods Matter?
Research Paper 190, 24 January 2024
By Patrick Juvet Lowé Gnintedem
Research Paper 190, 24 January 2024
By Patrick Juvet Lowé Gnintedem
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/12/RP-188-400x400.png)
The Intersection Between Intellectual Property, Public Health and Access to Climate-Related Technologies
Research Paper 188, 7 December 2023
By Lívia Regina Batista
Research Paper 188, 7 December 2023
By Lívia Regina Batista
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/11/RP-186-400x400.png)
Patentamiento de anticuerpos monoclonales. El caso de Argentina
Documento de Investigación 186, 14 de noviembre de 2023
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
Documento de Investigación 186, 14 de noviembre de 2023
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/09/RP-184-400x400.png)
Promoting Jordan’s Use of Compulsory Licensing During the Pandemic
Research Paper 184, 15 September 2023
By Laila Barqawi
Research Paper 184, 15 September 2023
By Laila Barqawi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/09/RP-180-400x400.png)
Neglected Dimension of the Inventive Step as Applied to Pharmaceutical and Biotechnological Products: The case of Sri Lanka’s patent law
Research Paper 180, 9 August 2023
By Ruwan Fernando
Research Paper 180, 9 August 2023
By Ruwan Fernando
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/06/RP-178-400x400.png)
A Response to COVID-19 and Beyond: Expanding African Capacity in Vaccine Production
Research Paper 178, 22 May 2023
By Carlos M. Correa
Research Paper 178, 22 May 2023
By Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/05/RP-176-rev-400x400.png)
Where Does Global Health Funding Come From and Where Does It Go?
Research Paper 176, 29 March 2023
By Germán Velásquez
Research Paper 176, 29 March 2023
By Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/03/RP-176-400x400.png)
De dónde viene y a dónde va el financiamiento para la salud mundial
Documento de Investigación 176, 29 de marzo de 2023
Por Germán Velásquez
Documento de Investigación 176, 29 de marzo de 2023
Por Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/03/RP-175-ES-400x400.png)
Experiencias internacionales sobre la concesión de licencias obligatorias por razones de salud pública
Documento de Investigación 175, 22 de marzo de 2023
Por Catalina de la Puente, Gastón Palopoli, Constanza Silvestrini, Juan Correa
Documento de Investigación 175, 22 de marzo de 2023
Por Catalina de la Puente, Gastón Palopoli, Constanza Silvestrini, Juan Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/02/RP-174-400x400.png)
Leading and Coordinating Global Health: Strengthening the World Health Organization
Research Paper 174, 13 February 2023
By Nirmalya Syam
Research Paper 174, 13 February 2023
By Nirmalya Syam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/02/RP-173-400x400.png)
Analysis of COVID-Related Patents for Antibodies and Vaccines
Research Paper 173, 7 February 2023
By Kausalya Santhanam
Research Paper 173, 7 February 2023
By Kausalya Santhanam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/02/PR-171_FR-400x400.png)
Directives pour l’examen des demandes de brevet relatives aux produits pharmaceutiques
Document de Recherche No. 171, 31 janvier 2023
Par Carlos M Correa
Document de Recherche No. 171, 31 janvier 2023
Par Carlos M Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/11/RP-171-400x400.png)
Pautas para el Examen de Solicitudes de Patentes Relacionadas con Productos Farmacéuticos
Documento De Investigación 171, 29 De Noviembre De 2022
Por Carlos M Correa
Documento De Investigación 171, 29 De Noviembre De 2022
Por Carlos M Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/11/RP-170-400x400.png)
Left on Our Own: COVID-19, TRIPS-Plus Free Trade Agreements, and the Doha Declaration on TRIPS and Public Health
Research Paper 170, 17 November 2022
By Melissa Omino and Joanna Kahumbu
Research Paper 170, 17 November 2022
By Melissa Omino and Joanna Kahumbu
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/11/RP-169-400x400.png)
The WTO TRIPS Decision on COVID-19 Vaccines: What is Needed to Implement it?
Research Paper 169, 8 November 2022
By Carlos M. Correa and Nirmalya Syam
Research Paper 169, 8 November 2022
By Carlos M. Correa and Nirmalya Syam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/10/RP-168-400x400.png)
TRIPS Flexibilities and Access to Medicines: An Evaluation of Barriers to Employing Compulsory Licenses for Patented Pharmaceuticals at the WTO
Research Paper 168, 28 October 2022
By Anna S.Y. Wong, Clarke B. Cole, Jillian C. Kohler
Research Paper 168, 28 October 2022
By Anna S.Y. Wong, Clarke B. Cole, Jillian C. Kohler
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/10/RP-165-front-cover-2-400x400.png)
Lessons From India’s Implementation of Doha Declaration on TRIPS and Public Health
Research Paper 166, 6 October 2022
By Nanditta Batra
Research Paper 166, 6 October 2022
By Nanditta Batra
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/09/RP-143-EN-400x400.png)
Brazilian Competition Law and Access to Health in Brazil: Exploitative Pricing in the Pharmaceutical Sector
Research Paper 143, 11 January 2022
By Bruno Braz de Castro
Research Paper 143, 11 January 2022
By Bruno Braz de Castro
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/07/RP-159-400x400.jpg)
Reaping the Fruits of Research on Microorganisms: Prospects and Challenges for R&D and Industry in Sri Lanka
Research Paper 159, 15 July 2022
by Ruwan Fernando
Research Paper 159, 15 July 2022
by Ruwan Fernando
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/06/RP-158-400x400.png)
Twenty Years After Doha: An Analysis of the Use of the TRIPS Agreement’s Public Health Flexibilities in India
Research Paper 158, 15 June 2022
by Muhammad Zaheer Abbas, PhD
Research Paper 158, 15 June 2022
by Muhammad Zaheer Abbas, PhD
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/05/RP-155-400x400.jpg)
Manufacturing for Export: A TRIPS-Consistent Pro-Competitive Exception
Research Paper 155, 27 May 2022
by Carlos M. Correa and Juan I. Correa
Research Paper 155, 27 May 2022
by Carlos M. Correa and Juan I. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/05/RP-154-3-400x400.png)
COVID-19 Vaccines as Global Public Goods: between life and profit
Research Paper 154, 9 May 2022
By Katiuska King Mantilla and César Carranza Barona
Research Paper 154, 9 May 2022
By Katiuska King Mantilla and César Carranza Barona
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/04/RP-153-web-400x400.png)
Patent Analysis for Medicines and Biotherapeutics in Trials to Treat COVID-19
Research Paper 153, 26 April 2022
By Srividya Ravi
Research Paper 153, 26 April 2022
By Srividya Ravi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/04/RP-152-3-400x400.png)
An Examination of Selected Public Health Exceptions in Asian Patent Laws
Research Paper 152, 21 April 2022
By Kiyoshi Adachi
Research Paper 152, 21 April 2022
By Kiyoshi Adachi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/04/RP-147-ES-400x400.jpg)
¿Podrán las negociaciones en la organización mundial de la salud resultar en un marco justo para la prevención, la preparación y la respuesta ante pandemias como bienes públicos globales?
Documento de investigación No. 147, 28 de febrero de 2022
Viviana Muñoz Tellez
Documento de investigación No. 147, 28 de febrero de 2022
Viviana Muñoz Tellez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/03/rp-147-400x400.jpg)
Les négociations au sein de l’Organisation mondiale de la santé peuvent-elles aboutir à un cadre juste pour la prévention, la préparation et la riposte aux pandémies en tant que bien public mondial?
Document de Recherche 147, 28 février 2022
Viviana Muñoz Tellez
Document de Recherche 147, 28 février 2022
Viviana Muñoz Tellez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/03/RP-147-400x400.png)
Can Negotiations at the World Health Organization Lead to a Just Framework for the Prevention, Preparedness and Response to Pandemics as Global Public Goods?
Research Paper 147, 28 February 2022
Viviana Muñoz Tellez
Research Paper 147, 28 February 2022
Viviana Muñoz Tellez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/02/RP-146-Front-Cover-3-400x400.png)
A Review of WTO Disputes on TRIPS: Implications for Use of Flexibilities for Public Health
Research Paper 146, 16 February 2022
Nirmalya Syam
Research Paper 146, 16 February 2022
Nirmalya Syam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/02/Right-to-Pharm-400x400.jpg)
The Right to Health in Pharmaceutical Patent Disputes
Research Paper 145, 9 February 2022
Emmanuel Kolawole Oke
Research Paper 145, 9 February 2022
Emmanuel Kolawole Oke
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/01/RP-144-400x400.png)
A TRIPS-COVID Waiver and Overlapping Commitments to Protect Intellectual Property Rights Under International IP and Investment Agreements
Research Paper 144, 27 January 2022
Henning Grosse Ruse-Khan and Federica Paddeu
Research Paper 144, 27 January 2022
Henning Grosse Ruse-Khan and Federica Paddeu
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/01/RP-143-400x400.jpg)
Direito Brasileiro da Concorrência e Acesso à Saúde no Brasil: Preços Exploratórios no Setor de Medicamentos
Research Paper 143, 11 de janeiro de 2022
Bruno Braz de Castro
Research Paper 143, 11 de janeiro de 2022
Bruno Braz de Castro
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/01/RP-142-2-400x400.jpg)
Competition Law and Access to Medicines: Lessons from Brazilian Regulation and Practice
Research Paper 142, 4 January 2022
Matheus Z. Falcão, Mariana Gondo and Ana Carolina Navarrete
Research Paper 142, 4 January 2022
Matheus Z. Falcão, Mariana Gondo and Ana Carolina Navarrete
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/11/rp-141-400x400.png)
Utilising Public Health Flexibilities in the Era of COVID-19: An Analysis of Intellectual Property Regulation in the OAPI and MENA Regions
Research Paper 141, November 2021
Yousuf A Vawda and Bonginkosi Shozi
Research Paper 141, November 2021
Yousuf A Vawda and Bonginkosi Shozi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/11/spanish-400x400.png)
Implementación de una exención de los ADPIC relacionados con tecnologías y productos sanitarios para la COVID-19: Evitar reclamaciones en virtud de acuerdos de libre comercio e inversión
Documento de investigación 135, Noviembre 2021
Carlos M. Correa, Nirmalya Syam y Daniel Uribe
Documento de investigación 135, Noviembre 2021
Carlos M. Correa, Nirmalya Syam y Daniel Uribe
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/11/french-400x400.png)
Mise en œuvre d’une dérogation ADPIC pour les technologies et produits de santé pour la COVID-19: prévenir les réclamations dans le cadre des accords de libre-échange et d’investissement
Document de Recherche 135, Novembre 2021
Carlos M. Correa, Nirmalya Syam et Daniel Uribe
Document de Recherche 135, Novembre 2021
Carlos M. Correa, Nirmalya Syam et Daniel Uribe
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/11/rp-400x400.png)
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
Documento de investigación 140, Noviembre 2021
Germán Velásquez
Documento de investigación 140, Noviembre 2021
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-136-400x400.jpg)
Canada’s Political Choices Restrain Vaccine Equity: The Bolivia-Biolyse Case
Research Paper 136, September 2021
Muhammad Zaheer Abbas, PhD
Research Paper 136, September 2021
Muhammad Zaheer Abbas, PhD
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-135-400x400.jpg)
Implementation of a TRIPS Waiver for Health Technologies and Products for COVID-19: Preventing Claims Under Free Trade and Investment Agreements
Research Paper 135, September 2021
Carlos M. Correa, Nirmalya Syam and Daniel Uribe
Research Paper 135, September 2021
Carlos M. Correa, Nirmalya Syam and Daniel Uribe
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-118-ES-400x400.png)
Repensando la fabricación mundial y local de productos médicos tras el COVID-19
Documento de investigación 118, Junio 2021
Germán Velásquez
Documento de investigación 118, Junio 2021
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-132-400x400.png)
Interpreting the Flexibilities Under the TRIPS Agreement
Research Paper 132, June 2021
Carlos M. Correa
Research Paper 132, June 2021
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-129-400x400.png)
The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines
Research Paper 129, March 2021
Henrique Zeferino de Menezes
Research Paper 129, March 2021
Henrique Zeferino de Menezes
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-118-FR-400x400.png)
Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19
Document de Recherche 118, Janvier 2021
Germán Velásquez
Document de Recherche 118, Janvier 2021
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-121-FR-400x400.png)
Les réformes de l’Organisation mondiale de la Santé a l’époque de COVID-19
Document de Recherche 121, Janvier 2021
Germán Velásquez
Document de Recherche 121, Janvier 2021
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-107-400x400.png)
Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
Documento de Investigación 107, Diciembre 2020
Dr. Carlos Correa
Documento de Investigación 107, Diciembre 2020
Dr. Carlos Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-125-400x400.png)
Designing Pro-Health Competition
Policies in Developing Countries
Research Paper 125, December 2020
Vitor Henrique Pinto Ido
Policies in Developing Countries
Research Paper 125, December 2020
Vitor Henrique Pinto Ido
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-121-SP-400x400.png)
Las reformas de la Organización Mundial de la Salud en la época de COVID-19
Documento de investigación 121, Noviembre 2020
Germán Velásquez
Documento de investigación 121, Noviembre 2020
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-124-400x400.png)
Practical Implications of ‘Vaccine Nationalism’: A Short-Sighted and Risky Approach in Response to COVID-19
Research Paper 124, November 2020
Muhammad Zaheer Abbas, PhD
Research Paper 124, November 2020
Muhammad Zaheer Abbas, PhD
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-121-400x400.png)
The World Health Organization Reforms in the Time of COVID-19
Research Paper 121, November 2020
Germán Velásquez
Research Paper 121, November 2020
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-120-400x400.png)
Patent Analysis for Medicines and Biotherapeutics in Trials to Treat COVID-19
Research Paper 120, October 2020
Srividya Ravi
Research Paper 120, October 2020
Srividya Ravi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-118-400x400.png)
Re-thinking Global and Local Manufacturing of Medical Products After COVID-19
Research Paper 118, September 2020
Dr. Germán Velásquez
Research Paper 118, September 2020
Dr. Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-116-400x400.png)
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic
Research Paper 116, August 2020
Frederick Abbott
Research Paper 116, August 2020
Frederick Abbott
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/RP-114-400x400.png)
Equitable Access to COVID-19 Related Health Technologies: A Global Priority
Research Paper 114, June 2020
Dr. Zeleke Temesgen Boru
Research Paper 114, June 2020
Dr. Zeleke Temesgen Boru
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2020/04/BookCover2-1-400x400.jpg)
Guide for the Granting of Compulsory Licenses and Government Use of Pharmaceutical Patents
Research Paper 107, April 2020
Dr. Carlos M. Correa
Research Paper 107, April 2020
Dr. Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2020/03/RP103ipweb-400x400.jpg)
Eighteen Years After Doha: An Analysis of the Use of Public Health TRIPS Flexibilities in Africa
Research Paper 103, February 2020
Yousuf A Vawda and Bonginkosi Shozi
Research Paper 103, February 2020
Yousuf A Vawda and Bonginkosi Shozi
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2020/03/RP101IPweb2-400x400.jpg)
Second Medical Use Patents – Legal Treatment and Public Health Issues
Research Paper 101, December 2019
Clara Ducimetière
Research Paper 101, December 2019
Clara Ducimetière
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2020/03/RP100IPweb-400x400.jpg)
Medicines and Intellectual Property: 10 Years of the WHO Global Strategy
Research Paper 100, December 2019
Dr. Germán Velásquez
Research Paper 100, December 2019
Dr. Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2019/09/RP96-ipaccessmeds-400x400.jpg)
Antivirales de acción directa para la Hepatitis C: evolución de los criterios de patentabilidad y su impacto en la salud pública en Colombia
Documento de Investigación 96, Agosto de 2019
Francisco A. Rossi B. y Claudia M. Vargas P.
Documento de Investigación 96, Agosto de 2019
Francisco A. Rossi B. y Claudia M. Vargas P.
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2019/04/RP85_IPAM-400x400.jpg)
Access to Medicines: Experiences with Compulsory Licenses and Government Use – The case of Hepatitis C
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2019/02/RP-90-ipweb-400x400.jpg)
Compulsory Licensing Jurisprudence in South Africa: Do We Have Our Priorities Right?
Research Paper 90, December 2018
Yousuf A Vawda
Research Paper 90, December 2018
Yousuf A Vawda
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-85-600x600.jpg)
Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C
Documento de Investigación 85, Mayo 2018
Germán Velásquez
Documento de Investigación 85, Mayo 2018
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-82-600x600.jpg)
The International Debate on Generic Medicines of Biological Origin
Research Paper 82, November 2017
Germán Velásquez
Research Paper 82, November 2017
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-62R-600x600.jpg)
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
Research Paper 62R, July 2017
Carlos M. Correa
Research Paper 62R, July 2017
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-78-600x600.jpg)
Intellectual Property, Public Health and Access to Medicines in International Organizations
Research Paper 78, July 2017
Germán Velásquez
Research Paper 78, July 2017
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-74-600x600.jpg)
Mitigating the Regulatory Constraints Imposed by Intellectual Property Rules under Free Trade Agreements
Research Paper 74, February 2017
Carlos M. Correa
Research Paper 74, February 2017
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-66-600x600.jpg)
The Bolar Exception: Legislative Models and Drafting Options
Research Paper 66, March 2016
Carlos M. Correa
Research Paper 66, March 2016
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-64-600x600.jpg)
Implementing Pro-Competitive Criteria for the Examination of Pharmaceutical Patents
Research Paper 64, February 2016
Carlos M. Correa
Research Paper 64, February 2016
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-59-600x600.jpg)
Transition Period for TRIPS Implementation for LDCs: Implications for Local Production of Medicines in the East African Community
Research Paper 59, December 2014
Nirmalya Syam
Research Paper 59, December 2014
Nirmalya Syam
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-58-600x600.jpg)
Patent Examination and Legal Fictions: How Rights are Created on Feet of Clay
Research Paper 58, December 2014
Carlos M. Correa
Research Paper 58, December 2014
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-56-600x600.jpg)
The African Regional Intellectual Property Organization (ARIPO) Protocol on Patents: Implications for Access to Medicines
Research Paper 56, November 2014
Sangeeta Shashikant
Research Paper 56, November 2014
Sangeeta Shashikant
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-47-600x600.jpg)
Access to Medicines and Intellectual Property: The Contribution of the World Health Organization
Research Paper 47, May 2013
Germán Velásquez
Research Paper 47, May 2013
Germán Velásquez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-41-600x600.jpg)
Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing
Research Paper 41, September 2011
Carlos M. Correa
Research Paper 41, September 2011
Carlos M. Correa
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/RP-35-600x600.jpg)
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy in Public Health, Innovation and Intellectual Property
Research Paper 35, January 2011
Germán Velásquez
Research Paper 35, January 2011
Germán Velásquez